Nghiem Lab Research Team Attends 8th Nordic/1st European Merkel Cell Carcinoma Meeting

Congratulations to members of the Nghiem Lab Research Team for presenting at the 8th Nordic/1st European Merkel Cell Carcinoma Meeting

www.nemcc.org

in Hamburg, Germany from Sept. 19-20, 2024. 

Presentation topics: 

Paul Nghiem, MD: Single postoperative dose of radiotherapy (8 Gy) has comparable efficacy to a standard 5-week course for localized Merkel cell carcinoma (and updates on ctDNA testing!)

Haroldo Rodriguez (Graduate Student): Germinal center B cell response in MCPyV-driven Merkel cell carcinoma associates with disease outcomes

Emily Gong (former Undergraduate Research Assistant): Immunosuppressed Merkel cell carcinoma patients frequently respond to immunotherapy but with significantly shorter durability: a 183-patient cohort

Krista Lachance (Research Manager): Working together to find cures: The Merkel cell carcinoma collaborative (MC3) Institute